Research News

Decreased risk of sudden death in heart failure questions need for ICDs

BMJ 2017; 358 doi: https://doi.org/10.1136/bmj.j3309 (Published 07 July 2017) Cite this as: BMJ 2017;358:j3309
  1. Susan Mayor
  1. London

The risk of sudden death in patients with symptomatic heart failure has halved over the past 20 years, a large study has reported.1 The authors suggest that the decrease is paralleled by greater use of evidence based drugs, such as angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers, and they question the benefit of implantable cardioverter defibrillators (ICDs) in most patients.

The study analysed data from …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe